Related Experiment Video

Updated: Jun 7, 2026

RhoC GTPase Activation Assay
09:58

RhoC GTPase Activation Assay

Published on: August 22, 2010

G protein-coupled receptor 30 in tumor development

Dengfeng Wang1, Lina Hu, Guonan Zhang

  • 1Department of Gynecological Oncology, Second People's Hospital of Sichuan (Sichuan Cancer Hospital), Sichuan, People's Republic of China.

Endocrine
|October 21, 2010
PubMed

Insights

A novel estrogen receptor, G protein-coupled receptor 30 (GPR30), drives tumor growth and drug resistance. Targeting GPR30, alongside classic estrogen receptors (ERs), offers a promising therapeutic strategy for estrogen-related cancers.

Area of Science:

  • Endocrinology
  • Oncology
  • Molecular Biology

Background:

  • Estrogen exerts significant physiological and pathological effects beyond the reproductive system.
  • Traditional estrogen signaling involves nuclear estrogen receptors (ERs).
  • A novel transmembrane estrogen receptor, G protein-coupled receptor 30 (GPR30), has emerged, influencing both rapid non-genomic and genomic estrogen actions.

Purpose of the Study:

  • To investigate the role of GPR30 in estrogen-related tumor progression.
  • To explore GPR30's involvement in mitogen-activated protein kinase (MAPK) signaling pathways.
  • To assess GPR30's potential as a therapeutic target, especially in cases of drug resistance.

Main Methods:

  • Review of existing literature on estrogen receptors and GPR30 function.
  • Analysis of GPR30's role in MAPK signaling in estrogen-related tumors.
  • Evaluation of GPR30's impact on therapeutic resistance.

Main Results:

  • GPR30 promotes estrogen-related tumor progression via MAPK signaling.
  • GPR30-mediated effects persist even when classic ERs are absent or blocked.
  • GPR30 is implicated in the development of drug resistance during cancer treatment.

Conclusions:

  • GPR30 represents a significant therapeutic target for estrogen-related tumors.
  • Simultaneous blockade of both GPR30 and classic ERs may enhance treatment efficacy.
  • Targeting GPR30 could overcome drug resistance in estrogen-dependent cancers.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...